Viral Vaccines

Displaying 1 - 4 of 4CSV
Embi, P. J., Levy, M. E., Patel, P., DeSilva, M. B., Gaglani, M., Dascomb, K., Dunne, M. M., Klein, N. P., Ong, T. C., Grannis, S. J., Natarajan, K., Yang, D.-H., Stenehjem, E., Zerbo, O., McEvoy, C., Rao, S., Thompson, M. G., Konatham, D., Irving, S. A., … Naleway, A. L. (2023). Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021. Vaccine, 41(37), 5424–5434. https://doi.org/10.1016/j.vaccine.2023.05.038
Publication Date
Sutton, M. S., Pletnev, S., Callahan, V., Ko, S., Tsybovsky, Y., Bylund, T., Casner, R. G., Cerutti, G., Gardner, C. L., Guirguis, V., Verardi, R., Zhang, B., Ambrozak, D., Beddall, M., Lei, H., Yang, E. S., Liu, T., Henry, A. R., Rawi, R., … Roederer, M. (2023). Vaccine elicitation and structural basis for antibody protection against alphaviruses. Cell, 186(12), 2672-2689.e25. https://doi.org/10.1016/j.cell.2023.05.019
Publication Date
Mishra, M., Zahra, A., Chauhan, L. V., Thakkar, R., Ng, J., Joshi, S., Spitzer, E. D., Marcos, L. A., Lipkin, W. I., & Mishra, N. (2022). A Short Series of Case Reports of COVID-19 in Immunocompromised Patients. Viruses, 14(5), 934. https://doi.org/10.3390/v14050934
Publication Date